| Stage | SLB | % of rev | HLX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.4B | 100.00% | $304M | 100.00% | SLB ×31.08 |
| Gross profit | $1.6B | 16.57% | $56M | 18.49% | HLX +1.9pp |
| Operating income | $1.1B | 11.47% | $27M | 8.79% | SLB +2.7pp |
| Pre-tax income | $1.0B | 10.78% | $22M | 7.37% | SLB +3.4pp |
| Net income | $780M | 8.25% | $23M | 7.47% | SLB +0.8pp |
| Stage | SLB | HLX | Gap · A − B |
|---|---|---|---|
| Revenue | $9.4B100.00% | $304M100.00% | SLB ×31.08 |
| Gross profit | 16.57%$1.6B | 18.49%$56M | HLX +1.9pp |
| Operating income | 11.47%$1.1B | 8.79%$27M | SLB +2.7pp |
| Pre-tax income | 10.78%$1.0B | 7.37%$22M | SLB +3.4pp |
| Net income |
| 8.25%$780M |
| 7.47%$23M |
| SLB +0.8pp |
No shared counterparties.